ProfK asked me to post on this There are reports of our friends in the EU and Astrazeneca are not having the best of arrangements. The rate of manufacture and delivery for the EU is pretty awful in terms of getting the supply of what the EU wants. LIkewise it seems the use of available stock has been pretty awful too. It kind of looks like an ugly divorce split with Astrazeneca being equated to the Brits. However, we have to remember Zeneca is a multinational and Astra is Swedish. Is that why the Danes, Norwegians, Icelandic people have put it on hold:-). Only joking. I am sure Zeneca would love to get some money from as many sources as they can…even if it is non-profit.
So you may have heard the news that many EU countries have halted vaccine use or batches of whole supplies due to a few cases of blood clots. From what I have read the European regulators have said that there is no evidence for a link and remember in the UK, we have vaccinated enough people with the Astrazeneca vaccine to have vaccinated everybody in Austria and Denmark. Add to the the other vaccines around the world, you would expect to have seen a clot safety signal if it was of major concern. We have to remember that people have strokes every day and if can happen in all sorts of ages and some infections can cause blood clots. However, rest assured the European Regulators will investigate this.
Can I explain this? Well simple answer is it is like being asked to explain a non-event. A quick search of adenovirus and clots and strokes did not really find anything. However, we know that infection with actual COVID-19 causes blood clots and COVID-19 disease have been associated with the develpment of strokes. Other viruses can cause blod clots. We will keep you posted
However, the good news for our European Friends is that they have a new treatment option in terms of the the Janssen/ the Johnson & Johnson vaccine. This have just been approved in EU. So the “Eagle has landed” again. Hopefully it will be exported to the EU soon. I am guessing this will get approval in the UK soon. This vaccine is currently a one off dose. A two shot dose is being tested in East London.